{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:21:40Z","timestamp":1772554900805,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00683-9","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:56:33Z","timestamp":1772502993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A rare diffuse follicular lymphoma with TP53 mutation and copy-neutral loss of heterozygosity at 1p36: insights into diagnosis, disease progression, and literature review"],"prefix":"10.1007","volume":"19","author":[{"given":"Mitra","family":"Abdolahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phassawan","family":"Rungsiprakarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Lazim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Jianming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Mackrides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Nejati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"20","key":"683_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"8","key":"683_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3324\/haematol.2013.086678","volume":"98","author":"ES Jaffe","year":"2013","unstructured":"Jaffe ES (2013) Follicular lymphomas: a tapestry of common and contrasting threads. Haematologica 98(8):1163\u20131165","journal-title":"Haematologica"},{"issue":"5","key":"683_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","volume":"113","author":"T Katzenberger","year":"2009","unstructured":"Katzenberger T, Kalla J, Leich E, St\u00f6cklein H, Hartmann E, Barnickel S et al (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113(5):1053\u20131061","journal-title":"Blood"},{"issue":"6","key":"683_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1365-2559.2007.02678.x","volume":"50","author":"C Thorns","year":"2007","unstructured":"Thorns C, Kalies K, Fischer U, H\u00f6fig K, Krokowski M, Feller AC et al (2007) Significant high expression of CD23 in follicular lymphoma of the inguinal region. Histopathology 50(6):716\u2013719","journal-title":"Histopathology"},{"issue":"1","key":"683_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1309\/AJCP27YWLIQRAJPW","volume":"135","author":"H Olteanu","year":"2011","unstructured":"Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH (2011) CD23 expression in follicular lymphoma: clinicopathologic correlations. Am J Clin Pathol 135(1):46\u201353","journal-title":"Am J Clin Pathol"},{"key":"683_CR6","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Araujo IB O, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"11","key":"683_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229\u20131253","journal-title":"Blood"},{"issue":"6","key":"683_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","volume":"10","author":"RR Xian","year":"2020","unstructured":"Xian RR, Xie Y, Haley LM, Yonescu R, Pallavajjala A, Pittaluga S et al (2020) CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. Blood Cancer J 10(6):69","journal-title":"Blood Cancer J"},{"issue":"7360","key":"683_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298\u2013303","journal-title":"Nature"},{"issue":"18","key":"683_CR10","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","volume":"122","author":"C B\u00f6d\u00f6r","year":"2013","unstructured":"B\u00f6d\u00f6r C, Grossmann V, Popov N, Okosun J, O\u2019Riain C, Tan K et al (2013) EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122(18):3165\u20133168","journal-title":"Blood"},{"issue":"4","key":"683_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","volume":"125","author":"C Correia","year":"2015","unstructured":"Correia C, Schneider PA, Dai H, Dogan A, Maurer MJ, Church AK et al (2015) BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 125(4):658\u2013667","journal-title":"Blood"},{"issue":"1","key":"683_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB et al (2014) Genetics of follicular lymphoma transformation. Cell Rep 6(1):130\u2013140","journal-title":"Cell Rep"},{"issue":"10","key":"683_CR13","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","volume":"123","author":"H Li","year":"2014","unstructured":"Li H, Kaminski MS, Li Y, Yildiz M, Ouillette P, Jones S et al (2014) Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. Blood 123(10):1487\u20131498","journal-title":"Blood"},{"issue":"17","key":"683_CR14","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1182\/bloodadvances.2022009467","volume":"7","author":"WR Burack","year":"2023","unstructured":"Burack WR, Li H, Adlowitz D, Spence JM, Rimsza LM, Shadman M et al (2023) Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma. Blood Adv 7(17):5082\u20135090","journal-title":"Blood Adv"},{"issue":"8","key":"683_CR15","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","volume":"112","author":"D O\u2019Shea","year":"2008","unstructured":"O\u2019Shea D, O\u2019Riain C, Taylor C, Waters R, Carlotti E, MacDougall F et al (2008) The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood 112(8):3126\u20133129","journal-title":"Blood"},{"issue":"6","key":"683_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/modpathol.2016.51","volume":"29","author":"IN Siddiqi","year":"2016","unstructured":"Siddiqi IN, Friedman J, Barry-Holson KQ, Ma C, Thodima V, Kang I et al (2016) Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol 29(6):570\u2013581","journal-title":"Mod Pathol"},{"issue":"22","key":"683_CR17","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","volume":"4","author":"D Nann","year":"2020","unstructured":"Nann D, Ramis-Zaldivar JE, M\u00fcller I, Gonzalez-Farre B, Schmidt J, Egan C et al (2020) Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. Blood Adv 4(22):5652\u20135665","journal-title":"Blood Adv"},{"issue":"6","key":"683_CR18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber ER, Lowe SW (2017) Putting p53 in Context. Cell 170(6):1062\u20131078","journal-title":"Cell"},{"issue":"7","key":"683_CR19","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","volume":"82","author":"CA Sander","year":"1993","unstructured":"Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES et al (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82(7):1994\u20132004","journal-title":"Blood"},{"key":"683_CR20","doi-asserted-by":"crossref","unstructured":"Khanlari M, Wang SA, Fowler NH, Tang G, Saluja K, Muzzafar T et al (2021) Concurrent TP53\u00a0mutation and deletion in refractory low-grade follicular lymphoma. Clin Lymphoma Myeloma Leuk 21(7):e626\u2013e629","DOI":"10.1016\/j.clml.2021.03.003"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00683-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:02:22Z","timestamp":1772546542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00683-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00683-9","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained for individual person\u2019s data included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}